Excerpts from Barclays Capital 2013 Global Healthcare Conference
"We also have a goal of reimbursement contracts for at least three national payers. And that would equate to more than doubling the lives under contract to 120 million by the end of this year."
"In our case, we are using the cash method of accounting for our revenue, for our diagnostic test. And as a result what you see is the cost being incurred upfront when we run the test, the revenue cycle particularly in the first year of launch may lag 120 even up to 180 days after the test is performed. So as a result it’s very difficult to predict so we use the cash basis. And ultimately our goal is to move to accrual accounting and only then we’ll – you have a better idea of matching the revenues and the expenses to do that, we need to put a billing process in-house, in-place. And our goal is to do that this year."